137 related articles for article (PubMed ID: 10931974)
1. Mechanisms of action of rabbit CAP18 on monolayers and liposomes made from endotoxins or phospholipids.
Gutsmann T; Fix M; Larrick JW; Wiese A
J Membr Biol; 2000 Aug; 176(3):223-36. PubMed ID: 10931974
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of interaction of rabbit CAP18 with outer membranes of gram-negative bacteria.
Gutsmann T; Larrick JW; Seydel U; Wiese A
Biochemistry; 1999 Oct; 38(41):13643-53. PubMed ID: 10521271
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial action of rabbit leukocyte CAP18(106-137).
Mason DJ; Dybowski R; Larrick JW; Gant VA
Antimicrob Agents Chemother; 1997 Mar; 41(3):624-9. PubMed ID: 9056004
[TBL] [Abstract][Full Text] [Related]
4. Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide.
Swierzko AS; Kirikae T; Kirikae F; Hirata M; Cedzynski M; Ziolkowski A; Hirai Y; Kusumoto S; Yokochi T; Nakano M
J Med Microbiol; 2000 Feb; 49(2):127-138. PubMed ID: 10670563
[TBL] [Abstract][Full Text] [Related]
5. Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids.
Gutsmann T; Hagge SO; Larrick JW; Seydel U; Wiese A
Biophys J; 2001 Jun; 80(6):2935-45. PubMed ID: 11371466
[TBL] [Abstract][Full Text] [Related]
6. Structure and functions of endotoxin-binding peptides derived from CAP18.
Hirata M; Zhong J; Wright SC; Larrick JW
Prog Clin Biol Res; 1995; 392():317-26. PubMed ID: 8524937
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of rabbit CAP18-derived peptides.
Larrick JW; Hirata M; Shimomoura Y; Yoshida M; Zheng H; Zhong J; Wright SC
Antimicrob Agents Chemother; 1993 Dec; 37(12):2534-9. PubMed ID: 8109914
[TBL] [Abstract][Full Text] [Related]
8. Anti-microbial activity of human CAP18 peptides.
Larrick JW; Hirata M; Zhong J; Wright SC
Immunotechnology; 1995 May; 1(1):65-72. PubMed ID: 9373334
[TBL] [Abstract][Full Text] [Related]
9. Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.
Ebbensgaard A; Mordhorst H; Overgaard MT; Nielsen CG; Aarestrup FM; Hansen EB
PLoS One; 2015; 10(12):e0144611. PubMed ID: 26656394
[TBL] [Abstract][Full Text] [Related]
10. A novel peptide-IgG conjugate, CAP18(106-138)-IgG, that binds and neutralizes endotoxin and kills gram-negative bacteria.
Fletcher MA; Kloczewiak MA; Loiselle PM; Ogata M; Vermeulen MW; Zanzot EM; Warren HS
J Infect Dis; 1997 Mar; 175(3):621-32. PubMed ID: 9041334
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity.
Hirata M; Shimomura Y; Yoshida M; Morgan JG; Palings I; Wilson D; Yen MH; Wright SC; Larrick JW
Infect Immun; 1994 Apr; 62(4):1421-6. PubMed ID: 8132348
[TBL] [Abstract][Full Text] [Related]
12. Rabbit CAP18 derived peptides inhibit gram negative and gram positive bacteria.
Larrick JW; Hirata M; Shimomoura Y; Yoshida M; Zheng H; Zhong J; Wright SC
Prog Clin Biol Res; 1994; 388():125-35. PubMed ID: 7831354
[TBL] [Abstract][Full Text] [Related]
13. Charge and aggregation pattern govern the interaction of plasticins with LPS monolayers mimicking the external leaflet of the outer membrane of Gram-negative bacteria.
Michel JP; Wang YX; Dé E; Fontaine P; Goldmann M; Rosilio V
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2967-79. PubMed ID: 26343162
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of a novel 32-amino acid C-terminal fragment of CAP18 in endotoxemic pigs.
VanderMeer TJ; Menconi MJ; Zhuang J; Wang H; Murtaugh R; Bouza C; Stevens P; Fink MP
Surgery; 1995 Jun; 117(6):656-62. PubMed ID: 7778029
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Lipopolysaccharide-Binding Antimicrobial Peptides Based on Truncated Rabbit and Human CAP18 Peptides and Evaluation of Their Action Mechanism.
Madanchi H; Ebrahimi Kiasari R; Seyed Mousavi SJ; Johari B; Shabani AA; Sardari S
Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1582-1593. PubMed ID: 32445120
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates.
Wiese A; Brandenburg K; Lindner B; Schromm AB; Carroll SF; Rietschel ET; Seydel U
Biochemistry; 1997 Aug; 36(33):10301-10. PubMed ID: 9254629
[TBL] [Abstract][Full Text] [Related]
17. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes.
Tossi A; Scocchi M; Skerlavaj B; Gennaro R
FEBS Lett; 1994 Feb; 339(1-2):108-12. PubMed ID: 8313956
[TBL] [Abstract][Full Text] [Related]
19. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Heumann D
J Immunol; 2001 Sep; 167(6):3329-38. PubMed ID: 11544322
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis.
Hammer MU; Brauser A; Olak C; Brezesinski G; Goldmann T; Gutsmann T; Andrä J
Biochem J; 2010 Apr; 427(3):477-88. PubMed ID: 20187872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
